CoChat

Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance

Open access
Bhat, Ajaz A., Younes, Salma N., Raza, Syed Shadab, Zarif, Lubna, Nisar, Sabah, Ahmed, Ikhlak, Mir, Rashid, Kumar, Sachin, Sharawat, Surender K., Hashem, Sheema, Elfaki, Imadeldin, Kulinski, Michal, Kuttikrishnan, Shilpa, Prabhu, Kirti S., Khan, Abdul Q., Yadav, Santosh K., El-Rifai, Wael, Zargar, Mohammad A., Zayed, Hatem, Haris, Mohammad, Uddin, Shahab · 2020 · Molecular Cancer
Cited by 164

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Early-stage detection of leukemia is a critical determinant for successful treatment of the disease and can increase the survival rate of leukemia patients. The factors limiting the current screening approaches to leukemia include low sensitivity and specificity, high costs, and a low participation rate. An approach based on novel and innovative biomarkers with high accuracy from peripheral blood offers a comfortable and appealing alternative to patients, potentially leading to a higher participation rate. Recently, non-coding RNAs due to their involvement in vital oncogenic processes such as differentiation, proliferation, migration, angiogenesis and apoptosis have attracted much attention as potential diagnostic and prognostic biomarkers in leukemia. Emerging lines of evidence have shown that the mutational spectrum and dysregulated expression of non-coding RNA genes are closely associated with the development and progression of various cancers, including leukemia. In this review, we highlight the expression and functional roles of different types of non-coding RNAs in leukemia and discuss their potential clinical applications as diagnostic or prognostic biomarkers and therapeutic targets.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12943-020-01175-9

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 164

Metadata

Authors
Bhat, A. A., Younes, S. N., Raza, S. S., Zarif, L., Nisar, S., Ahmed, I., Mir, R., Kumar, S., Sharawat, S. K., Hashem, S., Elfaki, I., Kulinski, M., Kuttikrishnan, S., Prabhu, K. S., Khan, A. Q., Yadav, S. K., El-Rifai, W., Zargar, M. A., Zayed, H., Haris, M., & Uddin, S.
Venue
Molecular Cancer
Published
2020-03-12
Volume
19
Issue
1
Pages
57-57
ISSN
1476-4598 (ISSN-L)
OpenAlex
W3011976559
Cited by
164
References
25
FWCI
6.04
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance. https://app.cochat.ai/papers/10.1186/s12943-020-01175-9
The paper
Bhat, A. A., Younes, S. N., Raza, S. S., Zarif, L., Nisar, S., Ahmed, I., Mir, R., Kumar, S., Sharawat, S. K., Hashem, S., Elfaki, I., Kulinski, M., Kuttikrishnan, S., Prabhu, K. S., Khan, A. Q., Yadav, S. K., El-Rifai, W., Zargar, M. A., Zayed, H., . . . Uddin, S. (2020). Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance. Molecular Cancer. https://doi.org/10.1186/s12943-020-01175-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.